The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Artelo Biosciences (ARTL) announced nonclinical results on ART12.11, its proprietary cocrystal composition of cannabidiol and ...